Precision medicine has increased survival rates - looking to AI for more

As scientists gain a deeper understanding of cancer, we have begun to tailor treatments to specific types of the disease. By putting a cancer tumor through advanced molecular testing, we can find out what proteins and genes are specific to this particular tumor and match it to the most effective treatment. The results are significant improvements in the survival rates of those patients fortunate enough to have a type of cancer for which a treatment is available. The trouble is, too few patients are so fortunate. Despite a great deal of cancer research conducted over the past few decades, only a handful of targeted therapies have reached clinical practice--between 8-and-15 percent of cancer patients in the US are eligible to receive targeted therapy.